If you find it hard to focus after a wakeful night, it’s because your brain is busy trying to catch up on crucial ...
NOVATO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced data demonstrating treatment with UX111 (ABO-102) AAV gene therapy resulted in rapid and ...
The blood-brain barrier prevents xenobiotics from entering the central nervous system. Growing evidence indicates that neurotoxins, such as tributyltin, manganese and nanoparticles, may disrupt the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback